Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
27,631,574
-
Share change
-
+803,374
-
Total reported value
-
$839,810,221
-
Put/Call ratio
-
54%
-
Price per share
-
$30.39
-
Number of holders
-
133
-
Value change
-
+$23,519,626
-
Number of buys
-
52
-
Number of sells
-
56
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2022
As of 30 Jun 2022,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,631,574 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, CPMG Inc, VANGUARD GROUP INC, BlackRock Inc., EcoR1 Capital, LLC, Camber Capital Management LP, BOXER CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Sofinnova Investments, Inc., and STATE STREET CORP.
This page lists
133
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.